Search
Loteprednol
go.drugbank.com/drugs/DB00873ApprovedInvestigationalWithdrawnLoteprednol is a corticosteroid. A more commonly used formulation of loteprednol is its ester, loteprednol etabonate.
Imazaquin
go.drugbank.com/drugs/DB04582ExperimentalCategories: Compounds used in a research, industrial, or household setting2,5-di-tert-butylhydroquinone
go.drugbank.com/drugs/DB04638ExperimentalCategories: Compounds used in a research, industrial, or household settingLixmabegagene relduparvovec
go.drugbank.com/drugs/DB16816InvestigationalIt is under development for the treatment of GM1 gangliosidosis.[L45929]
Theralizumab
go.drugbank.com/drugs/DB15717InvestigationalAfter the first human trial, it was withdrawn due to severe toxicity (likely due to lymphopenia and human cytokine release).[A216527,A216532]
Omburtamab
go.drugbank.com/drugs/DB15635Investigational[A242487, A242492] Omburtamab, formerly the murine anti-B7-H3 antibody 8H9, and its humanized forms are currently under clinical development for use in various cancers. … [A191829] Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/leptomeningeal Metastases).
Carbomer homopolymer type C
go.drugbank.com/drugs/DB14091InvestigationalCarbomer homopolymer type C is a high molecular polyanionic substance tested for antiulcerogenic activity.
Categories: Compounds used in a research, industrial, or household settingPotassium triiodide
go.drugbank.com/drugs/DB14492InvestigationalCategories: Compounds used in a research, industrial, or household settingIoglunide
go.drugbank.com/drugs/DB21276ExperimentalIoglunide is a small molecule drug. Ioglunide has a monoisotopic molecular weight of 806.86 Da.
Categories: Compounds used in a research, industrial, or household settingIcotinib
go.drugbank.com/drugs/DB11737InvestigationalIcotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc